ARNA
Price:
$99.99
Market Cap:
$0
Arena Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to developing innovative therapeutic agents, specifically designed with distinct pharmacological and pharmacokinetic profiles, for a global patient population. Its extensive pipeline features several key investigational medicines. Etrasimod (APD334) is undergoing diverse clinical evaluations, including a Phase III study for ulcerative colitis, a Phase IIb/III trial for Crohn's disease, a Phase II trial for alopecia areata, a separate Phase III trial for atopic dermatitis, and a Phase IIb study for eosinophilic esophagitis. Olorinab (APD371) is currently in a Phase IIb clinical trial, targeting abdominal discomfort linked to ir...[Read more]
Industry
Biotechnology
IPO Date
2000-07-28
Stock Exchange
NASDAQ
Ticker
ARNA
According to Arena Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 8.59. This represents a change of -44.86% compared to the average of 15.57 of the last 4 quarters.
The mean historical Current Ratio of Arena Pharmaceuticals, Inc. over the last ten years is 8.17. The current 8.59 Current Ratio has changed 10.41% with respect to the historical average. Over the past ten years (40 quarters), ARNA's Current Ratio was at its highest in in the June 2019 quarter at 36.51. The Current Ratio was at its lowest in in the March 2017 quarter at 1.85.
Average
8.17
Median
4.81
Minimum
1.88
Maximum
19.62
Discovering the peaks and valleys of Arena Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 295.98%
Maximum Annual Current Ratio = 19.62
Minimum Annual Increase = -56.23%
Minimum Annual Current Ratio = 1.88
| Year | Current Ratio | Change |
|---|---|---|
| 2021 | 8.59 | -56.23% |
| 2020 | 19.62 | 16.08% |
| 2019 | 16.90 | 9.74% |
| 2018 | 15.40 | 295.98% |
| 2017 | 3.89 | 107.21% |
| 2016 | 1.88 | -46.44% |
| 2015 | 3.50 | 29.77% |
| 2014 | 2.70 | -23.22% |
| 2013 | 3.52 | -38.53% |
| 2012 | 5.72 | 36.35% |
The current Current Ratio of Arena Pharmaceuticals, Inc. (ARNA) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
15.03
5-year avg
12.88
10-year avg
8.17
Arena Pharmaceuticals, Inc.’s Current Ratio is less than IVERIC bio, Inc. (18.63), greater than Reata Pharmaceuticals, Inc. (6.75), greater than Abcam plc (1.13), less than Roivant Sciences Ltd. (18.37), greater than Mirati Therapeutics, Inc. (6.96), less than Cerevel Therapeutics Holdings, Inc. (10.92), greater than Opthea Limited (0.22), greater than SpringWorks Therapeutics, Inc. (4.33), greater than R1 RCM Inc. (1.83), greater than MorphoSys AG (3.08),
| Company | Current Ratio | Market cap |
|---|---|---|
| 18.63 | $5.51B | |
| 6.75 | $6.57B | |
| 1.13 | $5.52B | |
| 18.37 | $21.61B | |
| 6.96 | $4.12B | |
| 10.92 | $8.19B | |
| 0.22 | $4.24B | |
| 4.33 | $3.54B | |
| 1.83 | $6.04B | |
| 3.08 | $2.86B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arena Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Arena Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Arena Pharmaceuticals, Inc.'s Current Ratio?
How is the Current Ratio calculated for Arena Pharmaceuticals, Inc. (ARNA)?
What is the highest Current Ratio for Arena Pharmaceuticals, Inc. (ARNA)?
What is the 3-year average Current Ratio for Arena Pharmaceuticals, Inc. (ARNA)?
What is the 5-year average Current Ratio for Arena Pharmaceuticals, Inc. (ARNA)?
How does the current Current Ratio for Arena Pharmaceuticals, Inc. (ARNA) compare to its historical average?